Caprock Group, Inc. Nautilus Biotechnology, Inc. Transaction History
Caprock Group, Inc.
- $4.08 Billion
- Q3 2025
A detailed history of Caprock Group, Inc. transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 17,090 shares of NAUT stock, worth $24,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,090
Previous 10,090
69.38%
Holding current value
$24,267
Previous $8,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NAUT
# of Institutions
74Shares Held
62.9MCall Options Held
158KPut Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$23.1 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$17.9 Million0.4% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$10.2 Million0.26% of portfolio
-
Madrona Venture Group, LLC6.02MShares$8.55 Million36.76% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$5.44 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $177M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...